Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 4

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

Authors Victor G Vogel

Published Date September 2008 Volume 2008:3(4) Pages 601—609

DOI http://dx.doi.org/10.2147/CIA.S3344

Published 16 September 2008

Victor G Vogel

The University of Pittsburgh Cancer Institute, Magee-Womens Hospital, Pittsburgh, PA, USA

Abstract: Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolism, and blood clotting. Raloxifene significantly improves serum lipids and serum markers of cardiovascular disease risk, but it has no significant effect on the risk of primary coronary events. A meta-analysis of randomized, double-blind, placebo-controlled trials of raloxifene for osteoporosis showed the odds of fracture risk were 0.60 (95% confidence interval [CI] = 0.49–0.74) for raloxifene 60 mg/day compared with placebo. During 8 years of follow-up in an osteoporosis trial, the raloxifene group had a 76% reduction in the incidence of invasive ER-positive breast cancer compared with the placebo group. In the STAR trial, the incidence of invasive breast cancer was 4.30 per 1000 women-years with raloxifene and 4.41 per 1000 with tamoxifen; RR = 1.02; 95% CI, 0.82–1.28. The effect of raloxifene on invasive breast cancer was, therefore, equivalent to that of tamoxifen with more favorable rates of adverse effects including uterine malignancy and clotting events. Millions of postmenopausal women could derive net benefit from raloxifene through reduced rates of fracture and invasive breast cancer.

Keywords: raloxifene, osteoporosis, breast cancer risk reduction

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Readers of this article also read:

Keeping an open mind: highlights and controversies of the breast cancer stem cell theory

Shah M, Allegrucci C

Breast Cancer: Targets and Therapy 2012, 4:155-166

Published Date: 26 October 2012

Concentration- and time-dependent response of human gingival fibroblasts to fibroblast growth factor 2 immobilized on titanium dental implants

Ma Q, Wang W, Chu PK, Mei S, Ji K, Jin L, Zhang Y,

International Journal of Nanomedicine 2012, 7:1965-1976

Published Date: 17 April 2012

Influence of cataract surgery and blood pressure changes caused by sodium restriction on retinal vascular diameter

Takatoshi Tano, Yoshimune Hiratsuka, Koichi Ono, et al

Clinical Ophthalmology 2010, 4:1299-1309

Published Date: 15 November 2010

Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease

Felix C Ringshausen, Ai-Yui M Tan, Tobias Allander, Irmgard Borg, Umut Arinir, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:111-117

Published Date: 4 February 2009

Clinical challenges in the management of osteoporosis

Sheryl F Vondracek, Paul Minne, Michael T McDermott

Clinical Interventions in Aging 2008, 3:315-329

Published Date: 30 June 2008

Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans

Farzaneh A Sorond, Lewis A Lipsitz, Norman K Hollenberg, Naomi DL Fisher

Neuropsychiatric Disease and Treatment 2008, 4:433-440

Published Date: 16 April 2008

Immunosupportive therapies in aging

Tamas Fülöp, Anis Larbi, Katsuiku Hirokawa, Eugenio Mocchegiani, Bruno Lesourd, et al

Clinical Interventions in Aging 2007, 2:33-54

Published Date: 16 May 2007

Immunological outcomes of exercise in older adults

David S Senchina, Marian L Kohut

Clinical Interventions in Aging 2007, 2:3-16

Published Date: 16 May 2007

Not Geropharmacotherapy 101

Albert J Finestone, Michael R Jacobs, John A Cacciamani

Clinical Interventions in Aging 2007, 2:715-718

Published Date: 3 January 2007